Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Management of Insomnia
Charles M. Morin, Daniel J. Buysse
New England Journal of Medicine (2024) Vol. 391, Iss. 3, pp. 247-258
Closed Access | Times Cited: 15
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W. Bürli, David G. Livermore, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129629-129629
Open Access | Times Cited: 8
Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches
R. de Bergeyck, Pierre A. Geoffroy
Revue Neurologique (2023) Vol. 179, Iss. 7, pp. 767-781
Closed Access | Times Cited: 15
Insomnia: A Current Review.
Sowjanya Naha, Manjamalai Sivaraman, Pradeep Sahota
PubMed (2024) Vol. 121, Iss. 1, pp. 44-51
Closed Access | Times Cited: 5
Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder
Cecilio Álamo, Jerónimo Sáiz Ruiz, Cristina Zaragozá Arnáez
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 2, pp. 172-182
Open Access | Times Cited: 5
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders
Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 378-378
Open Access
Orexin and Insomnia: Rethinking the Narrative
Jean‐Arthur Micoulaud‐Franchi, Christophe Gauld, Pierre Philip
Journal of Sleep Research (2025)
Closed Access
Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders
Marion Le Meur, Jaime Pignatelli, Paolo Blasi, et al.
Advanced Drug Delivery Reviews (2025), pp. 115561-115561
Open Access
The function of sleep and the treatment of primary insomnia
Wolfgang Freund, Frank Weber
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 10
Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study
Mariana Fernandes, Fabio Placidi, Nicola Biagio Mercuri, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 3443-3448
Open Access | Times Cited: 3
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
Giuseppe Cicala, María Antonietta Barbieri, Giulia Russo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 342-342
Open Access | Times Cited: 3
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?
Alice Caldiroli, Letizia Maria Affaticati, Enrico Capuzzi, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Deciphering Post-Stroke Sleep Disorders: Unveiling Neurological Mechanisms in the Realm of Brain Science
Pinqiu Chen, Wenyan Wang, Weikang Ban, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 307-307
Open Access | Times Cited: 2
Bioactive compounds from Ocimum tenuiflorum and Poria cocos: A novel natural Compound for insomnia treatment based on A computational approach
Onggan Ranteh, Aman Tedasen, Md. Atiar Rahman, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108491-108491
Closed Access | Times Cited: 2
Transfer of the Dual Orexin Receptor Antagonist Daridorexant into Breast Milk of Healthy Lactating Women
Priska Kaufmann, Clemens Muehlan, Marion Anliker‐Ort, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 10, pp. 1278-1287
Open Access | Times Cited: 2
Orexin neurons mediate temptation-resistant voluntary exercise
Alexander L. Tesmer, X.-L. Li, Edward F. Bracey, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 9, pp. 1774-1782
Open Access | Times Cited: 1
Tranquilizer und Hypnotika
Gerhard Gründer
Elsevier eBooks (2024), pp. 91-110
Closed Access | Times Cited: 1
Sleep and Circadian Disturbances in Children With Neurodevelopmental Disorders
Sharon Tamir, Thomas J. Dye, Rochelle M. Witt
Seminars in Pediatric Neurology (2023) Vol. 48, pp. 101090-101090
Open Access | Times Cited: 4
Danavorexton (TAK-925): an orexin receptor 2 agonist as a new ‘arousal’ agent
David G. Lambert, Kazuyoshi Hirota
British Journal of Anaesthesia (2024) Vol. 132, Iss. 3, pp. 466-468
Closed Access | Times Cited: 1
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Dispropor-tionality Analysis of Publicly Available FAERS Data
Giuseppe Cicala, María Antonietta Barbieri, Giulia Russo, et al.
(2024)
Open Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
The enigma of sleep
Davis C. Thomas, Tanvee Somaiya, Miguel Meira e Cruz, et al.
The Journal of the American Dental Association (2024) Vol. 155, Iss. 9, pp. 735-746
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top